40
Participants
Start Date
September 15, 2025
Primary Completion Date
June 15, 2028
Study Completion Date
June 15, 2030
hCG
Subcutaneous injection of 250 µg of recombinant hCG (Ovitrelle®)
University Hospital, Montpellier
OTHER